Clinical and paraclinical manifestations of autoimmune hepatitis in 48 patients from Medellín, Colombia;Manifestaciones clínicas y paraclínicas de la hepatitis autoinmune en 48 pacientes de la ciudad de Medellín, 1980-2004

Iatreia

Volumn 18, Issue 2, 2005, Pages 160-166

  Arango Barrientos, Marcos ^a   Díaz Coronado, Juan Camilo ^a   Ortega Castrillón, Juan Carlos ^a   Restrepo Zapata, Julio César ^a   Correa Arango, Gonzalo ^b   Restrepo Gutiérrez, Juan Carlos ^c   Donado Gómez, Jorge Hernando ^d  

^a UNIVERSIDAD PONTIFICIA BOLIVARIANA   (Colombia)

^b UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^c U de A Grupo de Gastrohepatología

^d UPB ^*  (Spain)

Author keywords

Autoimmune hepatitis; Autoimmunity

Indexed keywords

ANTINUCLEAR ANTIBODY; AZATHIOPRINE; BILIRUBIN; IMMUNOGLOBULIN; PREDNISONE;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; CLINICAL ARTICLE; CLINICAL FEATURE; COLOMBIA; COMORBIDITY; DEMOGRAPHY; FATIGUE; FEMALE; HUMAN; JAUNDICE; LIVER BIOPSY; LIVER HISTOLOGY; MALE; SOCIAL STATUS; THYROIDITIS;

EID: 23444457132     PISSN: 01210793     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. MCFARLANE I. Definition and classification of autoimmune hepatitis. Semin Liver Dis 2002; 22: 317-324.
2. CZAJA A. Autoimmune liver disease. Curr Opin Gastroenterol 2004; 20: 231-240.
3. th ed. Philadelphia: W. B. Saunders. 2002; 1.462-1.473.
4. LIMIDI JK, HYDE GM. Evaluation of abnormal liver function tests. Postgrad Med J 2003; 79: 307-312.
5. STRASSBURG CP, MANNS MP. Autoantibodies and autoantigens in autoimmune hepatitis. Semin Liver Dis 2002; 22: 339-352.
6. BEN-ARI Z, CZAJA A. Autoimmune hepatitis and its variant syndromes. Gut 2001; 49: 589-594.
7. STRASSBURG CP, MANNS MP. Autoimmune hepatitis. Best Pract Res Clin Gastroenterol 2003; 17: 291-306.
8. MCFARLANE I. Autoimmune hepatitis: diagnostic criteria, subclassifications and clinical features. Autoimmune hepatitis. Clin Liver Dis 2002; 6: 605-621.
9. CZAJA A, FREESE D. Diagnosis and treatment of autoimmune hepatitis. Hepatology 2002; 36: 479-497.
10. HENEGHAN MA, MCFARLANE I. Current and novel immunosuppressive therapy for autoimmune hepatitis. Hepatology 2002; 35: 7-13.
11. CZAJA A. Treatment of autoimmune hepatitis. Semin Liver Dis 2002; 22: 365-377.
12. WOODWARD J, NEUBERGER J. Autoimmune overlap syndromes. Hepatology 2001; 33: 994-1.002.
13. ALVAREZ F, BERG P, BIANCHI F, BIANCHI L, BURROUGHS A, CANCADO L, et al. International Autoimmune Hepatitis Group Report: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-938.
14. LONDOÑO MC, GONZÁLEZ CHAVARRIAGA JE, MUNERA V, RAMOS F, SUÁREZ LD, et al. Aplicación del modelo diagnóstico del Grupo Internacional para la Hepatitis Autoinmune (GIHA) en una población de pacientes de Medellín, Colombia. Rev Colomb Gastroenterol 2003; 18: 16-19.
15. MIELI-VERGANI G, VERGANI D. Autoimmune hepatitis in children. Autoimmune hepatitis. Clin Liver Dis 2002; 6: 623-634.
16. ZOLFINO T, HENEGHAN MA, NORRIS S, HARRISON PM, PORTMANN BC, MCFARLANE IG. Characteristics of autoimmune hepatitis in patients who are not of European Caucasoid ethnic origin. Gut 2002; 50: 713-717.
17. FELD JJ, HEATHCOTE EJ. Epidemiology of autoimmune liver disease. J Gastroenterol Hepatol 2003: 18: 1.118-1.128.
18. CZAJA A, MENON K, CARPENTER H. Sustained remission after corticosteroid therapy of type 1 autoimmune hepatitis: a retrospective analysis. Hepatology 2002; 35: 890-897.
19. YOUSSEF W, TAVILL A. Connective tissue diseases and the liver. J Clin Gastroenterol 2002; 35: 345-349.
20. IWAI M, HARADA Y, ISHII M, TANAKA M, MURAMATSU A, MORI T, et al. Autoimmune hepatitis in a patient with systemic lupus erythematosus. Clin Rheumatol 2003; 22: 234-236.